KRecwvaS
MHecct es
PA. tees
A033 354
REPOSIT!oryCenter Germintowr nd .
COLLECTION
BOX No.
Col
Oc
it.
ladt
TS.
-
Cclecsi fied Feb/mar i194
|
uo
—————
ae
,
he
bebeee
a
FOLDEA
[omane
Ths dommmens cotsisls cH ae
DR. JOHN C. BUQHER, MD, DIRECTOR
DIVISION OF BIOLOGY AND MEDICINE
ATOMIC ENERGY COMMISSION
WASHINOTON, De Ce
1, asst
ceca,
PRIORITY
BEST COPY AVAILABLE
VIA SECRETARY OF STATE
mse
os
JOHN ALLISON
AMBASSADOR
U. S. EMGASSY
TOKYO
INFO:
OR. JOHN J. MORTON, JR. AND MR. MERRIL KISENDUD
BEUR 2380 APRIL 1 NOON. IM VIEW ANTAGONISTIC ATTITUDE JAPAIESE PHYSICIANS AND
SCIENTISTS AS SHOWN IN THEIR REFISAL TO PERMIT AMERICAN HEVIEW AND PARTICIPATION
TB CLINICAL STUDIES, FEEL THAT MO ADWICE RELATIVE TREATMENT CAN BE GIVEN ON
HEARSAY INFORMATION.
SITUATION APPEARS TO US PREDOMINENTLY DIPLOMATIC WITH
THJURED FISHERMEN PAWNS IN MORE ELABORATE GAME.
SUGGEST THAT JAPANESE OFFI~
CIALS BE INFORMED THAT FURTHER U. S. MEDICAL INTEREST WILL BE CONDITIONED ON:
Le
IMMEDIATE AMD FULL COOPERATION IN ALL MEDICAL AND SCIENTIFIC ASPECTS,
INCLUDING COMPLETE ACCESS TO ALL IMDIVIDUALS AFFECTED.
@.
UNAESTRICTED AND CAREFUL DEVELOPMENT OF DETAILED CLINICAL DATA IMq
CLUDING AT LEAST THE FOLLOWING:
(#8) MINIMAL DAILY BLOOD STUDIES TO DNCLUDE
HED BLOOD CELL COUNT, HEMAOQLOHIN, HEMATOCRIT, TOTAL WHITE BLOOD CELL COUN,
DIFFERENTIAL WHITE COUNT AND PLATELETS HEPEAT PLATELETS.
522)
BOBROWN:mlh
1630 pom
x61]
,
_
2 of
wt
PoE,oeOEeison Oegeeceibibhereshisn
0000350
.
(b)
R&ECAPITULATION
noEaaw
eo
cr
oa
,